In recent decades, research on perceptual experiences has expanded beyond clinical constructs to include subclinical manifestations, such as psychotic experiences (PE), psychotic-like experiences (PLE), and unusual sensory experiences (USE) (
1,
2). According to psychosis spectrum theory, these subthreshold experiences can occur in the general population without causing functional impairment (
3).
Unusual sensory experiences, sometimes termed unusual perceptual experiences, are transient unimodal or multimodal sensory perceptions characterized by a mismatch between what is experienced and the external environment (
2). Although USE, PLE, and PE are sometimes used interchangeably (
4), in this study, we focus on USE as a broad phenomenological category of sensory disturbances, encompassing both subclinical, non-impairing hallucinations (perceptions without external stimuli) and misperceptions (distortions of real stimuli) observed in healthy individuals and clinical groups (
2). In this context, we conceptually distinguish USE from PE and PLE because PE and PLE include delusion- or hallucination-like occurrences, as well as negative features such as anhedonia or apathy, within the psychosis spectrum (
5).
Consistent with this distinction, a key feature of USE is their unimodal versus multimodal nature. Although the literature has focused primarily on auditory experiences (
6), recent studies have provided rigorous evidence across various dimensions of USE (
7). Studies have suggested that, even within the psychosis spectrum framework, which conceptualizes perceptual anomalies broadly, the emphasis remains on explicit experiences such as visual or auditory phenomena rather than on more phenomenological and ambiguous perceptual experiences such as bodily sensations, despite their potential to cause discomfort (
8). Research has indicated that multimodal hallucinations, considered here a subset of USE and varying in timing (consecutively or simultaneously), content, or origin, have a greater impact on an individual's mental health than unimodal hallucinations (
9).
Given the multimodal nature of USE and the limited tools available for assessing them within modality-specific frameworks, Mitchell et al. (
2) developed the MUSEQ as a valid instrument supported by confirmatory factor analysis. The MUSEQ was developed using a sample of 1,300 participants, including members of the general population, clinical groups, and students (
2).
In Iran, assessment tools for perceptual anomalies are mainly limited to Persian adaptations of instruments such as the Launay-Slade Hallucination Scale (LSHS) and the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE), which assess hallucination proneness and unusual experiences as one dimension of broader schizotypy traits, respectively (
10,
11). Unlike these instruments, the MUSEQ provides separate subscale scores for each sensory modality: visual, auditory, olfactory, gustatory, bodily sensations, and sensed presence (
2). To our knowledge, no validated Persian instrument specifically assesses USE across multiple sensory modalities. Moreover, a Persian adaptation of the MUSEQ would enable Iranian clinicians and researchers to examine modality-specific USE profiles and facilitate future research and structured assessment of sensory processing without conflating it with psychotic pathology.
Students at medical sciences universities constitute a large and academically diverse population in Iran. To date, no study in Iran has evaluated USE in this group using a modality-specific instrument.